In the Women’s Health Initiative Hormone Replacement Therapy clinical trial, a subset of older women were identified as having pelvic organ prolapse. The precise prevalence of pelvic organ prolapse is not known because there are different classification systems and women do not initially seek medical attention for prolapse.